Attached files
| file | filename |
|---|---|
| EX-99.1 - UPTICK PRESS RELEASE - Can B Corp | exhibit99_1.htm |
| EX-99.2 - COMPANY PRESS RELEASE - Can B Corp | exhibit99_2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
August 7, 2018
Date of Report (Date of earliest event reported)
Canbiola, Inc.
(Exact name of registrant as specified in its charter)
Florida | 333-208293 | 20-3624118 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
960 South Broadway, Suite 120 |
| 11801 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: 516-205-4751
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company X
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01. Other Events
On August 7, 2018, Uptick Newswire issued a press release regarding its interview of the CEO and the Chief Medical Advisor for Canbiola, Inc. (the “Company”) on its “Stock Day” podcast. Within the interview, the Company’s CEO, Marco Alfonsi, references a Press Release of the Company’s from July 9, 2018. Copies of both Uptick’s and the Company’s releases referenced above are included herewith as Exhibits.
The information in the press releases and the Uptick interview are not to be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed herewith.
Exhibit No. |
| Description |
Uptick Press Release | ||
Company Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Canbiola, Inc. |
| ||
|
|
|
| |
Date: August 7, 2018 | By: | /s/ Marco Alfonsi Marco Alfonsi, CEO |
| |
|
| |||